Atrial fibrillation is a risk marker for worse in-hospital and long-term outcome in patients with peripheral artery disease

International Journal of Cardiology

Volumn 199, Issue , 2015, Pages 223-228

  Wasmer, Kristina ^a   Unrath, Michael ^b   Köbe, Julia ^a   Malyar, Nasser M ^a   Freisinger, Eva ^a   Meyborg, Matthias ^a   Breithardt, Günter ^a   Eckardt, Lars ^a   Reinecke, Holger ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF OSNABRÜCK   (Germany)

Author keywords

Atrial fibrillation; Outcome; Peripheral artery disease

Indexed keywords

ACUTE KIDNEY FAILURE; AGE DISTRIBUTION; AGED; ARTICLE; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CRITICAL LIMB ISCHEMIA; DIABETES MELLITUS; DISEASE CLASSIFICATION; DISEASE MARKER; FEMALE; HEALTH CARE COST; HEART ATRIUM FLUTTER; HEART DEATH; HEART FAILURE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; LENGTH OF STAY; LIMB AMPUTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; RUTHERFORD CLASSIFICATION; SEPSIS; CAUSE OF DEATH; CLINICAL TRIAL; COMPLICATION; FOLLOW UP; HOSPITAL MORTALITY; HOSPITAL PATIENT; MULTICENTER STUDY; PERIPHERAL ARTERIAL DISEASE; PREVALENCE; PROCEDURES; RETROSPECTIVE STUDY; TIME FACTOR; TRENDS;

AGED; ATRIAL FIBRILLATION; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; INPATIENTS; MALE; PERIPHERAL ARTERIAL DISEASE; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84941556054     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.06.094     Document Type: Article

References (22)

1. J.P. Depta, and D.L. Bhatt Atherothrombosis and atrial fibrillation: important and often overlapping clinical syndromes Thromb. Haemost. 104 2010 657 663
2. S. Goto, D.L. Bhatt, J. Röther, and et al. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis Am. Heart J. 156 2008 855 863
3. ACTIVE Writing Group of the ACTIVE Investigators, S. Connolly, J. Pogue, and et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (active w): a randomised controlled trial Lancet 367 2006 1903 1912
4. ACTIVE Investigators, S.J. Connolly, J. Pogue, and et al. Effect of clopidogrel added to aspirin in patients with atrial fibrillation N. Engl. J. Med. 360 2009 2066 2078
5. R. Nieuwlaat, A. Capucci, A.J. Camm, and et al. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart survey on atrial fibrillation Eur. Heart J. 26 2005 2422 2434
6. J.B. Olesen, G.Y. Lip, D.A. Lane, and et al. Vascular disease and stroke risk in atrial fibrillation: a nationwide cohort study Am. J. Med. 125 2012 826
7. M. Nabauer, A. Gerth, T. Limbourg, and et al. The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management Europace 11 2009 423 434
8. D.S. Conway, and G.Y. Lip Comparison of outcomes of patients with symptomatic peripheral artery disease with and without atrial fibrillation (the West Birmingham Atrial Fibrillation Project) Am. J. Cardiol. 93 2004 1422 1425
9. B. Anandasundaram, D.A. Lane, S. Apostolakis, and G.Y.H. Lip The impact of atherosclerotic vascular disease in predicting a stroke, thromboembolism and mortality in atrial fibrillation patients: a systematic review J. Thromb. Haemost. 11 2013 975 987
10. J.B. Olesen, L. Fauchier, D.A. Lane, S. Taillandier, and G.Y. Lip Risk factors for stroke and thromboembolism in relation to age among patients with atrial fibrillation: the loire valley atrial fibrillation project Chest 141 2012 147 153
11. G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation Chest 137 2010 263 272
12. P. Brønnum Nielsen, F. Skjøth, L.H. Rasmussen, T. Bjerregaard Larsen, and G.Y.H. Lip Using the CHADS-VASc score for stroke prevention in atrial fibrillation: a focus on vascular disease, females and simple practical application Can. J. Cardiol. 31 2015 820.e9 820.e10
13. L.-Y. Lin, C.-H. Lee, C.-C. Yu, C.-T. Tsai, L.-P. Lai, J.-J. Hwang, P.-C. Chen, and J.-L. Lin Risk factors and incidence of ischemic stroke in Taiwanese with nonvalvular atrial fibrillation - a nationwide database analysis Atherosclerosis 217 2011 292 295
14. E. Aguilar, A.M. García-Díaz, J.F. Sánchez Muñoz-Torrero, and et al. Clinical outcome of stable outpatients with coronary, cerebrovascular or peripheral artery disease, and atrial fibrillation Thromb. Res. 130 2012 390 395
15. M. Pohlen, H. Bunzemeier, W. Husemann, N. Roeder, G. Breithardt, and H. Reinecke Risk predictors for adverse outcomes after percutaneous coronary interventions and their related costs Clin. Res. Cardiol. 97 2008 441 448
16. H. Reinecke, M. Unrath, E. Freisinger, H. Bunzemeier, M. Meyborg, F. Lüders, K. Gebauer, N. Roeder, K. Berger, and N.M. Malyar Peripheral arterial disease and critical limb ischemia - still poor outcomes and lack of guideline adherence Eur. Heart J. 36 2015 932 938
17. T.W. Rooke, A.T. Hirsch, S. Misra, and et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J. Am. Coll. Cardiol. 61 2013 1555 1570
18. European Stroke Organisation, M. Tendera, V. Aboyans, and et al. ESC guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the task force on the diagnosis and treatment of peripheral artery diseases of the European Society of Cardiology (ESC) Eur. Heart J. 32 2011 2851 2906
19. P.C. Austin An introduction to propensity score methods for reducing the effects of confounding in observational studies Multivar. Behav. Res. 46 2011 399 424
20. W.B. Kannel, R.D. Abbott, D.D. Savage, and P.M. McNamara Epidemiologic features of chronic atrial fibrillation: the Framingham study N. Engl. J. Med. 306 1982 1018 1022
21. E.J. Benjamin, P.A. Wolf, R.B. D'Agostino, H. Silbershatz, W.B. Kannel, and D. Levy Impact of atrial fibrillation on the risk of death: the Framingham heart study Circulation 98 1998 946 952
22. S. Stewart, C.L. Hart, D.J. Hole, and J.J. McMurray A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study Am. J. Med. 113 2002 359 364